Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for STRATA Skin Sciences (SSKN) over the last 13 years, with Q3 2025 value amounting to 16.93%.

  • STRATA Skin Sciences' EBITDA Margin rose 13200.0% to 16.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 31.3%, marking a year-over-year decrease of 55300.0%. This contributed to the annual value of 27.58% for FY2024, which is 17800.0% down from last year.
  • According to the latest figures from Q3 2025, STRATA Skin Sciences' EBITDA Margin is 16.93%, which was up 13200.0% from 29.02% recorded in Q2 2025.
  • In the past 5 years, STRATA Skin Sciences' EBITDA Margin ranged from a high of 1.26% in Q4 2022 and a low of 44.75% during Q4 2024
  • For the 5-year period, STRATA Skin Sciences' EBITDA Margin averaged around 21.92%, with its median value being 18.61% (2022).
  • As far as peak fluctuations go, STRATA Skin Sciences' EBITDA Margin surged by 275700bps in 2021, and later tumbled by -408700bps in 2023.
  • STRATA Skin Sciences' EBITDA Margin (Quarter) stood at 6.87% in 2021, then surged by 118bps to 1.26% in 2022, then plummeted by -3233bps to 39.6% in 2023, then dropped by -13bps to 44.75% in 2024, then surged by 62bps to 16.93% in 2025.
  • Its last three reported values are 16.93% in Q3 2025, 29.02% for Q2 2025, and 29.58% during Q1 2025.